Sarepta Therapeutics, Inc. — Director's Dealing 2016

Mar 3, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2016-02-29

Reporting Person: Price Ben Gil (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-29	Common Stock	A	1000	$0.00	Acquired	38330	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-29	Non-Qualified Stock Option (right to buy)	$13.71	A	10500	Acquired	2026-02-28	Common Stock (10500)	Direct

Footnotes

F1: This Restricted Stock Award will vest in full on the first anniversary of the Issuer's next annual meeting of stockholders.

F2: This option will vest at a rate of 1/24th of the total option amount granted on a monthly basis over two years commencing on the first monthly anniversary of Issuer's 2016 annual meeting of stockholders.